Use of ingredients in infant formula for special medical purposes
Taiwan
Sep 30, 2022
The Taiwan Food and Drug Administration (TFDA) consulted on the amendment to the use restriction of 2′-fucosyllactose (2′-FL) produced by genetically modified Escherichia coli strain K-12 DH1 MDO MAP1001d (hereinafter referred to as “E. coli K-12 MAP1001d”) and genetically modified Escherichia coli strain BL21 (DE3) #1540 (hereinafter referred to as “E. coli BL21 (DE3) #1540”).
For further information (in Chinese), click on the Link